SEARCH

SEARCH BY CITATION

References

  • 1
    Barbara L, Okuda K, Taylor KJW, Groszmann RJ. The value of Doppler US in the study of hepatic hemodynamics (Consensus conference). J Hepatol 1990; 10: 353355.
  • 2
    Sabbà C, Weltin GG, Cicchetti DV, Ferraioli G, Taylor KJW, Nakamura T, Moriyasu F, et al. Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology 1990; 98: 16031611.
  • 3
    Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, Kanematsu Y, et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 1986; 14: 579588.
  • 4
    Zoli M, Marchesini G, Cordiani MR, Pisi P, Brunori A, Trono A, Pisi E. Echo-Doppler measurement of splanchnic blood flow in control and in cirrhotic subjects. J Clin Ultrasound 1986; 14: 429435.
  • 5
    Taylor KJW, Holland S. Doppler ultrasound. I. Basic principles, instrumentation and pitfalls. Radiology 1990; 174: 297307.
  • 6
    Sabba C, Ferraioli G, Buonamico P, Berardi E, Antonica G, Taylor KJW, Albano O. Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter. J Hepatol 1992; 15: 356360.
  • 7
    Gosling RGI, Dunbar G, King DH, Newman DL, Side CD, Woodcock JP, Fritzgerald DE. The quantitative analysis of occlusive peripheral arterial disease by non-intrusive ultrasonic technique. Angiology 1971; 22: 5255.
  • 8
    Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultra-sonography. Hepatology 1993; 17: 219224.
  • 9
    Voet D, Afschrift M, Duprez D, De Buyzere M, Barbier F. Influence of isosorbide dinitrate on superior mesenteric artery impedance in humans. Cardiovasc Drugs Ther 1993; 7: 169174.
  • 10
    Hoefs JC. Portal hypertension. In: GitnickG, ed. Principles and practice of gastroenterology and hepatology. New York: Elsevier, 1988; 12251267.
  • 11
    Bosch J, Pizcueta P, Feu F, Fernandez H, Garcia-Pagan CG. Pathophysiology of portal hypertension. Gastroent Clin North Am 1992; 21: 114.
  • 12
    MacMathuma P, Vlavianos P, Westaby D, Williams R. Pathophysiology of portal hypertension. Dig Dis 1992; 10(suppl 1): 315.
  • 13
    Sabba C, Ferraioli G, Buonamico P, Mahal T, Taylor KJW, Ler-ner E, Albano O, et al. A randomized study of propranolol on postprandial hyperemia in cirrhotic patients. Gastroenterology 1992; 102: 10091016.
  • 14
    Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 1995; 108: 11521158.
  • 15
    Williams R, Condon RE, Williams HS, Blendis LM, Kreel K. Splenic blood flow in cirrhosis and portal hypertension. Clin Sci 1968; 34: 441452.
  • 16
    Gusberg RJ, Peterec SM, Sumpio BE, Meier GH. Splenomegaly and variceal bleeding: hemodynamic basis and treatment implications. Hepatogastroenterology 1994; 41: 573577.
  • 17
    Beppu K, Inokuchi K, Koyanagy N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213218.
  • 18
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal vari-ces. Br J Surg 1973; 60: 646649.
  • 19
    Bolognesi M, Sacerdoti D, Merkel C, Gatta A. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients. J Ultrasound Med 1994; 13: 945952.
  • 20
    Moriyasu F, Nishida O, Ban N, Nakamura T, Sakai M, Miyake T, Uchino H. “Congestion index” of the portal vein. AJR 1986; 143: 735739.
  • 21
    Gatta A, Sacerdoti D, Merkel C, Battaglia G, Milani L, Zuin R. Effect of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. Am Heart J 1984; 108: 11671172.
  • 22
    Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci GF, Sacerdoti D, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal vari-ces. Gastroenterology 1992; 102: 973979.
  • 23
    Moriyasu F, Nishida O, Ban N, Nakamura T, Miura K, Sakai M, Miyake T, et al. Measurement of portal vascular resistance in patients with portal hypertension. Gastroenterology 1986; 90: 710712.
  • 24
    Rifkin MD, Neefleman L, Pasto ME, Kurtz AB, Foy PM, McGlynn E, Canino C, et al. Evaluation of renal transplant rejection by duplex Doppler examination: value of the resistive index. AJR 1987; 148: 759762.
  • 25
    Hadengue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, Bernuau J, et al. Persistence of systemic and splanchnic hy-perkinetic circulation in liver transplant patients. Hepatology 1993; 17: 175178.
  • 26
    Navasa M, Feu F, Garcia-Pagan JC, Jimenez W, Llach J, Rimola A, Bosch J, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355360.
  • 27
    Merkel C, Gatta A, Arnaboldi L, Zuin R. Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin Physiol 1985; 5: 531539.
  • 28
    Westaby D, Wilkinson SP, Warren R, Williams R. Spleen size and portal hypertension. Digestion 1978; 17: 6368.